TG THERAPEUTICS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
TG THERAPEUTICS, INC. (TGTX) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$2.37 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2023-11-06
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-09-30 was -$21.51M.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-06-30 was $9.28M.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2023-03-31 was $9.86M.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-12-31 was $16.43M, a 321.07% increase year-over-year.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$11.01M, a 168.85% decline from fiscal 2021.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2021 was $15.99M, a 37.49% increase from fiscal 2020.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2020 was $11.63M.
- TG THERAPEUTICS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2019 was -$4.79M, a 143.76% decline from fiscal 2018.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month as first filed | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 13 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 15 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 16 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 18 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 19 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 22 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 25 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 28 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 119 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | -$21.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$12.23M derived: sum of 2 quarters · filed 2023-11-06 | -$2.37M 10-Q · filed 2023-11-06 | $14.05M derived: sum of 4 quarters · filed 2023-11-06 | ||||||||||||||
| 2023-06-30 | $9.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $19.14M 10-Q · filed 2023-08-04 | $35.56M derived: sum of 3 quarters · filed 2023-08-04 | $29.48M derived: sum of 4 quarters · filed 2023-11-06 | ||||||||||||||
| 2023-03-31 | $9.86M 10-Q · filed 2023-05-08 | $26.28M derived: sum of 2 quarters · filed 2023-05-08 | $20.20M derived: sum of 3 quarters · filed 2023-11-06 | $9.02M derived: sum of 4 quarters · filed 2023-11-06 | ||||||||||||||
| 2022-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $10.35M derived: sum of 2 quarters · filed 2023-11-06 | -$840.00K derived: sum of 3 quarters · filed 2023-11-06 | -$11.01M 10-K · filed 2023-03-01 | ||||||||||||||
| 2022-09-30 | -$6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$17.27M derived: sum of 2 quarters · filed 2023-11-06 | -$27.44M 10-Q · filed 2023-11-06 | -$23.54M derived: sum of 4 quarters · filed 2023-11-06 | ||||||||||||||
| 2022-06-30 | -$11.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$21.36M 10-Q · filed 2023-08-04 | -$17.45M derived: sum of 3 quarters · filed 2023-08-04 | -$8.63M derived: sum of 4 quarters · filed 2023-08-04 | ||||||||||||||
| 2022-03-31 | -$10.17M 10-Q · filed 2023-05-08 | -$6.27M derived: sum of 2 quarters · filed 2023-05-08 | $2.55M derived: sum of 3 quarters · filed 2023-05-08 | $4.92M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||||||||
| 2021-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.72M derived: sum of 2 quarters · filed 2023-03-01 | $15.09M derived: sum of 3 quarters · filed 2023-03-01 | $15.99M 10-K · filed 2023-03-01 | ||||||||||||||
| 2021-09-30 | $8.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $11.19M derived: sum of 2 quarters · filed 2022-11-09 | $12.09M 10-Q · filed 2022-11-09 | $17.83M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2021-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.27M 10-Q · filed 2022-08-09 | $9.01M derived: sum of 3 quarters · filed 2023-03-01 | $15.63M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2021-03-31 | $904.00K 10-Q · filed 2022-05-10 | $6.64M derived: sum of 2 quarters · filed 2023-03-01 | $13.26M derived: sum of 3 quarters · filed 2023-03-01 | $14.10M derived: sum of 4 quarters · filed 2023-03-01 | ||||||||||||||
| 2020-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.36M derived: sum of 2 quarters · filed 2023-03-01 | $13.20M derived: sum of 3 quarters · filed 2023-03-01 | $11.63M 10-K · filed 2023-03-01 | ||||||||||||||
| 2020-09-30 | $6.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $7.46M derived: sum of 2 quarters · filed 2021-11-08 | $5.89M 10-Q · filed 2021-11-08 | $4.93M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-06-30 | $839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$728.00K 10-Q · filed 2021-08-06 | -$1.69M derived: sum of 3 quarters · filed 2022-03-01 | $65.00K derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2020-03-31 | -$1.57M 10-Q · filed 2021-05-10 | -$2.52M derived: sum of 2 quarters · filed 2022-03-01 | -$774.00K derived: sum of 3 quarters · filed 2022-03-01 | -$8.60M derived: sum of 4 quarters · filed 2022-03-01 | ||||||||||||||
| 2019-12-31 | -$958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $793.00K derived: sum of 2 quarters · filed 2022-03-01 | -$7.04M derived: sum of 3 quarters · filed 2022-03-01 | -$4.79M 10-K · filed 2022-03-01 | ||||||||||||||
| 2019-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$6.08M derived: sum of 2 quarters · filed 2020-11-09 | -$3.84M 10-Q · filed 2020-11-09 | -$5.20M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2019-06-30 | -$7.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$5.59M 10-Q · filed 2020-08-10 | -$6.95M derived: sum of 3 quarters · filed 2021-03-01 | -$3.53M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2019-03-31 | $2.24M 10-Q · filed 2020-05-11 | $876.00K derived: sum of 2 quarters · filed 2021-03-01 | $4.30M derived: sum of 3 quarters · filed 2021-03-01 | $7.91M derived: sum of 4 quarters · filed 2021-03-01 | ||||||||||||||
| 2018-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.06M derived: sum of 2 quarters · filed 2021-03-01 | $5.67M derived: sum of 3 quarters · filed 2021-03-01 | $10.96M 10-K · filed 2021-03-01 | ||||||||||||||
| 2018-09-30 | $3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $7.03M derived: sum of 2 quarters · filed 2019-11-12 | $12.32M 10-Q · filed 2019-11-12 | $20.68M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2018-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.90M 10-Q · filed 2019-08-09 | $17.25M derived: sum of 3 quarters · filed 2020-03-02 | $16.85M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2018-03-31 | $5.29M 10-Q · filed 2019-05-10 | $13.65M derived: sum of 2 quarters · filed 2020-03-02 | $13.24M derived: sum of 3 quarters · filed 2020-03-02 | $13.76M derived: sum of 4 quarters · filed 2020-03-02 | ||||||||||||||
| 2017-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $7.95M derived: sum of 2 quarters · filed 2020-03-02 | $8.47M derived: sum of 3 quarters · filed 2020-03-02 | $11.02M 10-K · filed 2020-03-02 | $11.02M 10-K · filed 2018-03-15 | |||||||||||||
| 2017-09-30 | -$402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $114.00K derived: sum of 2 quarters · filed 2018-11-09 | $2.67M 10-Q · filed 2018-11-09 | $2.67M 10-Q · filed 2017-11-09 | $2.71M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2017-06-30 | $516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.07M 10-Q · filed 2018-08-09 | $3.07M 10-Q · filed 2017-08-09 | $3.11M derived: sum of 3 quarters · filed 2019-03-01 | $5.85M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2017-03-31 | $2.55M 10-Q · filed 2018-05-10 | $2.55M 10-Q · filed 2017-05-10 | $2.60M derived: sum of 2 quarters · filed 2019-03-01 | $5.33M derived: sum of 3 quarters · filed 2019-03-01 | $10.62M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2016-12-31 | $45.78K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $2.78M derived: sum of 2 quarters · filed 2019-03-01 | $8.07M derived: sum of 3 quarters · filed 2019-03-01 | $6.49M 10-K · filed 2019-03-01 | $6.49M 10-K · filed 2017-03-16 | |||||||||||||
| 2016-09-30 | $2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $8.02M derived: sum of 2 quarters · filed 2017-11-09 | $6.45M 10-Q · filed 2017-11-09 | $7.26M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.71M 10-Q · filed 2017-08-09 | $4.52M derived: sum of 3 quarters · filed 2018-03-15 | $5.16M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-03-31 | -$1.58M 10-Q · filed 2017-05-10 | -$763.19K derived: sum of 2 quarters · filed 2018-03-15 | -$123.83K derived: sum of 3 quarters · filed 2018-03-15 | -$539.87K derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2015-12-31 | $812.79K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.45M derived: sum of 2 quarters · filed 2018-03-15 | $1.04M derived: sum of 3 quarters · filed 2018-03-15 | $5.47M 10-K · filed 2018-03-15 | ||||||||||||||
| 2015-09-30 | $639.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $223.31K derived: sum of 2 quarters · filed 2016-11-09 | $4.66M 10-Q · filed 2016-11-09 | $785.12K derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | -$416.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.02M 10-Q · filed 2016-08-09 | $145.76K derived: sum of 3 quarters · filed 2017-03-16 | $6.42M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $4.43M 10-Q · filed 2016-05-10 | $561.81K derived: sum of 2 quarters · filed 2017-03-16 | $6.83M derived: sum of 3 quarters · filed 2017-03-16 | $7.72M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.40M derived: sum of 2 quarters · filed 2017-03-16 | $3.29M derived: sum of 3 quarters · filed 2017-03-16 | -$603.38K 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | $6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $7.16M derived: sum of 2 quarters · filed 2015-11-09 | $3.27M 10-Q · filed 2015-11-09 | $3.89M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-06-30 | $886.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$3.00M 10-Q · filed 2015-08-10 | -$2.38M derived: sum of 3 quarters · filed 2016-03-15 | -$185.38K derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-03-31 | -$3.89M 10-Q · filed 2015-05-11 | -$3.27M derived: sum of 2 quarters · filed 2016-03-15 | -$1.07M derived: sum of 3 quarters · filed 2016-03-15 | -$94.83K derived: sum of 4 quarters · filed 2016-03-15 | $1.15M 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | $621.69K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.82M derived: sum of 2 quarters · filed 2016-03-15 | $3.79M derived: sum of 3 quarters · filed 2016-03-15 | $4.03M 10-K · filed 2016-03-15 | $5.04M 10-K · filed 2014-03-07 | |||||||||||||
| 2013-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $3.17M derived: sum of 2 quarters · filed 2014-11-14 | $3.41M 10-Q · filed 2014-11-14 | $2.50M derived: sum of 4 quarters · filed 2014-11-14 | $4.42M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $976.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $1.22M 10-Q · filed 2014-07-24 | $308.10K derived: sum of 3 quarters · filed 2014-07-24 | $900.94K derived: sum of 4 quarters · filed 2014-07-24 | $2.22M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | $240.99K 10-Q · filed 2014-05-14 | -$668.79K derived: sum of 2 quarters · filed 2014-05-14 | -$75.94K derived: sum of 3 quarters · filed 2014-05-14 | $1.09M derived: sum of 4 quarters · filed 2014-05-14 | $1.25M 10-Q · filed 2013-05-14 | |||||||||||||
| 2012-12-31 | -$909.77K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$316.93K derived: sum of 2 quarters · filed 2014-03-07 | $850.36K derived: sum of 3 quarters · filed 2014-03-07 | $595.76K 10-K · filed 2014-03-07 | $1.00M 10-K · filed 2013-03-21 | |||||||||||||
| 2012-09-30 | $592.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.76M derived: sum of 2 quarters · filed 2013-11-14 | $1.51M 10-Q · filed 2013-11-14 | $1.91M derived: sum of 4 quarters · filed 2013-11-14 | $1.91M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $912.68K 10-Q · filed 2013-08-09 | $1.32M derived: sum of 3 quarters · filed 2013-08-09 | $1.32M derived: sum of 4 quarters · filed 2013-08-09 | $1.32M 10-Q/A · filed 2012-09-07 | |||||||||||||
| 2012-03-31 | -$254.60K 10-Q · filed 2013-05-14 | $153.71K derived: sum of 2 quarters · filed 2013-05-14 | $153.71K derived: sum of 3 quarters · filed 2013-05-14 | $153.71K 10-Q · filed 2012-05-14 | ||||||||||||||
| 2011-12-31 | $408.31K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $408.31K derived: sum of 2 quarters · filed 2013-03-21 | $408.31K 10-K · filed 2013-03-21 | |||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | -$55.80K 10-Q · filed 2011-11-14 | -$178.10K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | -$15.87K 10-Q/A · filed 2011-09-14 | -$138.18K 10-Q/A · filed 2011-09-14 | |||||||||||||||
| 2010-09-30 | $22.02K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$332.97K 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | -$354.99K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |